Gastric US in ICU Patient
- Conditions
- Aspiration PneumoniaCritical IllnessSurgery
- Registration Number
- NCT05526105
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Brief Summary
This is a case series study using gastric ultrasound in critically ill patients to quantify gastric residual volumes to compare the efficacy of different NPO protocols.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
- Patients age 18 or older, admitted to the ICU, requiring general anesthesia or sedation for a procedure with a pre-existing, cuffed endotracheal or tracheostomy tube. Most patients admitted to the ICU would be unable to consent.
- Known upper gastrointestinal anatomical problem that would prevent accurate estimation of gastric volume, gastric perforation, pregnancy beyond the first trimester.
- Lack of a pre-existing, cuffed endotracheal or tracheostomy tube.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Gastric Residual Volumes Within one hour of operative intervention. Quantification of gastric residual volumes as measured in milliliters using antral cross-sectional areas and semi-quantitative gastric volumes using standardized grading scores.
- Secondary Outcome Measures
Name Time Method Peri-operative aspiration events Within four months of study completion, 16 months from study start Number of aspiration events per number of operative interventions.
Estimation of the amount of enteral nutrition lost prior to surgery using the different NPO protocols Zero to sixteen hours prior to surgery Calculation of enteral nutrition held during NPO time in kilocalories.
Comparison of two different NPO protocol populations Within four months of study completion, 16 months from study start Comparing standard ASA NPO protocol vs liberal, feed-up-until-call to OR protocol as defined by comparison of gastric volumes (mLs).
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Dartmouth Hitchcock Medical Center
🇺🇸Lebanon, New Hampshire, United States
Dartmouth Hitchcock Medical Center🇺🇸Lebanon, New Hampshire, United StatesLaura Chiang, MDContactlaura.m.chiang@hitchcock.org
